share_log

Ono Pharmaceutical 1H Net Y46.29B Vs Net Y39.85B

Ono Pharmaceutical 1H Net Y46.29B Vs Net Y39.85B

小野製藥1H淨值46.29億日元vs淨值39.85億日元
Dow Jones Newswires ·  2021/10/31 23:00 

    Ono Pharmaceutical Co. Ltd. (4528.TO) 
    Osaka 
    1st Half Ended September 30 
GROUP                2021                 2020 
Revenue              Y174.08 bln   Y150.47 bln 
Operating Profit     Y58.17 bln     Y52.40 bln 
Pretax Profit        Y59.23 bln     Y53.67 bln 
Net Profit           Y46.29 bln     Y39.85 bln 
Per share 
  Earnings           Y92.74             Y79.84 
  Diluted Earnings   Y92.73             Y79.83 
    Results are based on IFRS accounting standards. 
小野藥業(4528.TO)大阪截至9月30日的上半年集團2021 2020營收1740.8億日元1504.7億日元營業利潤581.7億日元524.億日元税前利潤592.3億日元536.7億日元淨利潤462.9億日元398.5億日元每股收益92.74日元79.84日元稀釋後收益92.73日元79.83日元結果是基於“國際財務報告準則”的會計準則。

This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.

此內容是基於來自原始源的數據和/或文本自動發佈的。如需反饋，請寫信至singaporeeders@dowjones.com。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論